Compared with patients in the normal hs-cTnI group, those in the elevated hs-cTnI group were older and showed a higher rate of diabetes, chronic kidney disease, and ejection fraction <50% and a lower use of statins. Here, TNNI3 is linked to chronic kidney disease.